Related Experiment Video
Updated: Aug 7, 2026

07:35
Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice
Published on: January 26, 2024
Hypoglycaemic shock: normal or abnormal response to injury?
R O Ofiaeli1, C C Anyaegbu, C E Dioka
1Department of Surgery, Nnamdi Azikiwe University, Anambra State, Nigeria.
Tropical Doctor
|August 13, 1998
Summary
Hypoglycaemic shock can occur in trauma patients up to 18 hours post-injury, challenging the assumption of hyperglycemia. Prompt dextrose administration rapidly restored consciousness in a case of severe hypoglycemia following trauma.
Area of Science:
- Trauma Medicine
- Endocrinology
- Emergency Medicine
Background:
- The metabolic response to trauma is typically characterized by a hyperglycaemic state due to stress hormones.
- Hypoglycemia is an uncommon but serious complication in trauma patients.
Observation:
- A patient involved in a road traffic accident sustained multiple rib fractures and lumbar bruising.
- The patient developed symptoms of hypoglycaemic shock, including weakness, sweating, disorientation, and coma, 18 hours after injury and 11 hours after his last meal.
Findings:
- Intravenous administration of 50 ml of 50% dextrose rapidly reversed the hypoglycaemic shock and restored consciousness.
- This case highlights that severe hypoglycaemia can manifest in trauma patients, contrary to the usual hyperglycaemic response.
Implications:
- Clinicians should consider the possibility of delayed hypoglycaemia in trauma patients, even in the absence of pre-existing diabetes.
- Early recognition and treatment of hypoglycaemia are crucial for preventing severe neurological complications in trauma cases.
- This case underscores the need for vigilant glucose monitoring in trauma patients, irrespective of the expected metabolic response.
Related Concept Videos
Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
Blood Pressure Imbalances and Circulatory Shock
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...

